PT  - JOURNAL ARTICLE
AU  - Hitt Nichols, Emma
ED  - Kröger, Nicolaus
TI  - Reduced-Dose Conditioning Comparable to Standard Dose Prior to ASCT in MDS
DP  - 2014  01
TA  - MD Conference Express
PG  - 20--21
VI  - 14
IP  - 55
4099  - http://mdc.sagepub.com/content/14/55/20.short
4100  - http://mdc.sagepub.com/content/14/55/20.full
AB  - New data from the RICMAC trial showed similar rates of non-relapse mortality, incidence of relapse, and relapse-free survival in patients with myelodysplastic syndrome or secondary acute myeloid leukemia after conditioning with reduced-dose busulfan plus fludarabine vs standard-dose busulfan plus cyclophosphamide prior to allogeneic stem cell transplantation. Overall survival was higher with the reduced dose, but results were not statistically significant.